PMDA — authorised 23 December 2023
- Marketing authorisation holder: AstraZeneca K.K.
- Status: approved
🇯🇵 Imjudo in Japan
PMDA authorised Imjudo on 23 December 2023
Marketing authorisation
Imjudo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Imjudo approved in Japan?
Yes. PMDA authorised it on 23 December 2023.
Who is the marketing authorisation holder for Imjudo in Japan?
AstraZeneca K.K. holds the Japanese marketing authorisation.